Spots Global Cancer Trial Database for A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer
Official Title: Post Marketing Trial (Phase IV) on the Safety, Tolerability And Efficacy of Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Study ID: NCT03583944
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate clinical and laboratory safety of eribulin mesylate in treating participants with locally advanced or metastatic breast cancer, who have progressed after at least one regimen of chemotherapy which has included anthracycline and taxane therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Sir Ganga Ram Hospital, New Delhi, Delhi, India
HEMATO-ONCOLOGY CLINIC Vedanta Institute of Medical Sciences, Ahmedabad, Gujarat, India
HealthCare Global Enterprises Ltd, Bangalore, Karnataka, India
Srinivasam Cancer Care Multispecialty Hospitals India Pvt Ltd, Bangalore, Karnataka, India
KR Hospital Mysore Medical College, Mysore, Karnataka, India
Tata Memorial Hospital Department of Oncology, Mumbai, Maharashtra, India
HCG NCHRI Cancer Centre, Nagpur, Maharashtra, India
Lokmanya Hospital, Pune, Maharashtra, India
All India Institute of Medical Sciences, Bhubaneswar, Orissa, India
Deep Hospital, Ludhiana, Punjab, India
Sawai Man Singh Hospital, Jaipur, Rajasthan, India
MNJ Institute of Oncology and Regional Cancer Centre, Hyderabad, Telangana, India
J.K.Cancer Institute, Kanpur, Uttar Pradesh, India
King George's Medical University,(Erstwhile Chhatrapati Shahuji Maharaj Medical University), Lucknow, Uttar Pradesh, India
Ajanta Research Centre, Ajanta Hospital & IVF Centre, Lucknow, Uttar Pradesh, India
Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal, India
Netaji Subhash Chandra Bose Cancer Institute, Kolkata, West Bengal, India
IPGME&R S.S.K.M Hospital, Kolkata, West Bengal, India
Contact Details
Name: Medical Director
Affiliation: Eisai Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
